首页> 外文期刊>European Journal of Pharmacology: An International Journal >FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies
【24h】

FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies

机译:FFA4受体(GPR120):抗糖尿病疗法发展的热点

获取原文
获取原文并翻译 | 示例
           

摘要

Free Fatty Acid 4 receptor (FFA4 receptor or GPR120), a rhodopsin-like G protein coupled receptor (GPM) subfamily member, is a receptor that senses specific fatty acids such as omega-3 fatty acid in fish oil or the endogenous signaling lipid, PHASA. FFA4 receptor is enriched in lung, colon and adipose tissue but is also detected in many other tissues and cells. The activation of FFA4 receptor has multiple effects, including but not limited to inhibition of inflammation, improving insulin sensitivity and adipogenesis, and regulating hormone secretion from the gastro-intestinal system and pancreatic islets. The important role of FFA4 receptor in maintaining metabolic homeostasis strongly indicates the great potential of selective FFA4 receptor agonizts to treat diabetes and inflammation. In this review, we summarize recent research progress in the physiological and biochemical studies of FFA4 receptor and highlight its underlying signaling mechanisms and ligand identification to assist future research to exploit FFA4 receptor as a drug target. (C) 2015 Elsevier B.V. All rights reserved
机译:游离脂肪酸4受体(FFA4受体或GPR120)是视紫红质样G蛋白偶联受体(GPM)的亚家族成员,是一种可感知特定脂肪酸的受体,例如鱼油中的omega-3脂肪酸或内源性信号脂质, PHASA。 FFA4受体富含肺,结肠和脂肪组织,但也可以在许多其他组织和细胞中检测到。 FFA4受体的激活具有多种作用,包括但不限于抑制炎症,改善胰岛素敏感性和成脂作用以及调节胃肠道系统和胰岛的激素分泌。 FFA4受体在维持代谢稳态中的重要作用强烈表明选择性FFA4受体激动剂在治疗糖尿病和炎症方面的巨大潜力。在这篇综述中,我们总结了FFA4受体的生理和生化研究的最新研究进展,并强调了其潜在的信号传导机制和配体鉴定,以协助将来的研究将FFA4受体用作药物靶标。 (C)2015 Elsevier B.V.保留所有权利

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号